scholarly journals Transforming Growth Factor-Beta Produced by Non-small Cell Lung Cancer Cells Contributes to Lung Fibroblast Contractile Phenotype

2018 ◽  
Vol 38 (4) ◽  
Keyword(s):  
Lung Cancer ◽  
Growth Factor ◽  
Small Cell Lung Cancer ◽  
Cancer Cells ◽  
Transforming Growth Factor Beta ◽  
Transforming Growth Factor ◽  
Small Cell ◽  
Lung Fibroblast ◽  
Small Cell Lung ◽  
Growth Factor Beta

P-169 Dose and volume-dependent changes of plasma transforming growth factor-beta during radiotherapy of non-small cell lung cancer

Lung Cancer ◽  
2003 ◽  
Vol 41 ◽  
pp. S133
Author(s):  
Katrien De Jaeger ◽  
Yvette Seppenwoolde ◽  
Harm H. Kampinga ◽  
Liesbeth J. Boersma ◽  
Jose S.A. Belderbos ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Growth Factor ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Transforming Growth Factor Beta ◽  
Transforming Growth Factor ◽  
Small Cell ◽  
Small Cell Lung ◽  
Growth Factor Beta

scholarly journals Genetic variations in the transforming growth factor-beta pathway as predictors of survival in advanced non-small cell lung cancer

2011 ◽  
Vol 32 (7) ◽  
pp. 1050-1056 ◽  
Author(s):  
Moubin Lin ◽  
David J. Stewart ◽  
Margaret R. Spitz ◽  
Michelle A.T. Hildebrandt ◽  
Charles Lu ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Growth Factor ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Transforming Growth Factor Beta ◽  
Transforming Growth Factor ◽  
Genetic Variations ◽  
Small Cell ◽  
Small Cell Lung ◽  
Growth Factor Beta

Association between genetic variations in transforming growth factor beta pathway and overall survival in patients with non-small cell lung cancer treated with definitive radiotherapy.

2012 ◽  
Vol 30 (15_suppl) ◽  
pp. e17530-e17530
Author(s):  
Weili Wang ◽  
Kerby A Shedden ◽  
Feng-Ming (Spring) Kong
Keyword(s):  
Lung Cancer ◽  
Overall Survival ◽  
Growth Factor ◽  
Transforming Growth Factor Beta ◽  
Transforming Growth Factor ◽  
Small Cell ◽  
Small Cell Lung ◽  
Definitive Radiotherapy ◽  
Growth Factor Beta ◽  
Tgfβ Pathway

e17530 Background: The transforming growth factor beta (TGFβ) pathway, an important regulator in cellular metabolic process, has been reported for significant association with cancer prognosis. This study was to exam the association between single nucleotide polymorphisms (SNPs) of TGFβ pathway and overall survival (OS) in subjects with non-small cell lung cancer (NSCLC). Methods: Patients with stage I-III NSCLC received definitive radiotherapy with/without chemotherapy were eligible to this prospective study. The primary endpoint was OS which was calculated from radiation treatment start to death or censored. DNA samples for genotyping were extracted from buffy-coat which was collected before commencement of treatment. 19 SNPs in 10 genes (BMP1, BMP2, INHBC, SMAD1, SMAD3, SMAD4, SMAD6, SMAD7, SMAD8, TGFβ1), which was reported to have significant correlation with OS of lung cancer, were selected. MassArray System (Sequenom Company) was used for genotyping. Cox regression was performed for multivariate analysis to examine the effects of genotypes on OS using dominant and recessive genetic model. Results: 126 consecutive patients, 91% of them were Caucasian, were recruited in this study. All SNPs call rates were over 90%. Assay reproducibility was over 99% by random double-blinding duplicate or triplicate genotyping. Among clinical factors analyzed, radiation dose was only significant independent factor predicting OS (P=0.001). Genotypic association study showed that 7 SNPs (rs235756, rs11939979, rs12102171, rs6494633, rs12456284, rs12906898 and rs4803455) were significantly associated with OS, adjusted for age, gender, smoking, histology, clinical stage, tumor volume, Karnofsky Performance Status, radiotherapy dose, and chemotherapy. The strongest association was in SMAD3: rs12102171 (P=0.004, HR=2.28, 95%CI, 1.26-4.15). Conclusions: This study partly validated findings from previous studies that genetic variations in the TGFβ pathway are significant predictors of overall survival in NSCLC patients treated with definitive radiotherapy with/without chemotherapy.

Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells

Steroids ◽  
2005 ◽  
Vol 70 (5-7) ◽  
pp. 372-381 ◽  
Author(s):  
R PIETRAS ◽  
D MARQUEZ ◽  
H CHEN ◽  
E TSAI ◽  
O WEINBERG ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Growth Factor ◽  
Small Cell Lung Cancer ◽  
Cancer Cells ◽  
Cell Lung Cancer ◽  
Growth Factor Receptor ◽  
Small Cell ◽  
Human Breast ◽  
Small Cell Lung ◽  
Receptor Interactions
Sign in / Sign up

Export Citation Format

Share Document